Privacy Policy All information provided will be used and protected (user data). When the user registers their data on this website, they automatically accept the rules of use, protection and security mentioned here. If the user decides not to accept the Privacy Policies, there may be information that they cannot
São Paulo, Brazil, March 26th 2026 – SteinCares, a leading specialty healthcare company in Latin America, today announced Brazil’s Agencia Nacional de Vigilância Sanitária, ANVISA, has approved the registration transfer for Spectrila®, an essential recombinant E. coli asparaginase biologic used in the treatment of Acute Lymphoblastic Leukemia (ALL). SteinCares will now
San Jose, Costa Rica and Karnataka, India — February 24th, 2026 — SteinCares, a leading specialty healthcare company in Latin America, and Shilpa Biologicals Pvt. Ltd., a fully integrated biopharmaceutical company and subsidiary of Shilpa Medicare Limited, announce a strategic licensing agreement to commercialize a biosimilar across Latin America. Under the agreement, SteinCares
San Jose, Costa Rica, January 19th, 2026 — SteinCares announced today that Moody’s Investors Service has assigned the company an AA credit rating with Stable outlook, highlighting its solid financial position, resilient business model, and disciplined operational execution across Latin America’s pharmaceutical sector. The rating recognizes SteinCares’ robust cash flow generation,
São Paulo, Brazil – December 8th 2025 SteinCares, a leading specialty healthcare company in Latin America, today announced the addition of Monofer® (iron isomaltoside 1000) into its Brazilian portfolio, following the recent transfer of commercialization rights. With this milestone, SteinCares strengthens its presence in Brazil and expands access to innovative treatments
San Jose, Costa Rica – August 26, 2025 – In line with its purpose to create healthcare opportunities across Latin America, SteinCares today announced the opening of its new secondary packaging facility in Costa Rica. This strategic investment is a milestone for SteinCares’ regional consolidation and will support its expansion and
San Jose, Costa Rica, July 28, 2025. SteinCares, a leading specialty healthcare company in Latin America operating in over 30 countries, today announced its official entry into the Mexican market through a strategic joint venture with Laboratorios Carnot, a leading Mexican pharmaceutical company with more than 80 years of experience in
Guangzhou, China and San Jose, Costa Rica, June 2025 —Bio-Thera Solutions, Ltd., a commercial-stage biopharmaceutical company developing a pipeline of innovative therapies and biosimilars, and SteinCares, a leading specialty healthcare company in Latin America, today announced the signing of a new agreement to commercialize a proposed biosimilar of dupilumab across Latin
Mumbai, Costa Rica, May 26, 2025: Global Pharma major Lupin Limited (Lupin) today announced that it has entered into a license and supply agreement with SteinCares, a leading specialty healthcare company in Latin America, for commercialization of Lupin’s biosimilar ranibizumab across Latin America excluding Mexico and Argentina. Under the terms
San Jose, Costa Rica, May 2025. SteinCares, a leading specialty healthcare company in Latin America, and Pharmacosmos, a leading international company that specializes in iron treatments have announced the launch of Monofer®—an innovative intravenous iron replacement therapy for those with a deficiency of this mineral—to six new markets: Ecuador, Dominican Republic, Guatemala,
